SCHEMBL10413966

SCHEMBL10413966

Cc1nc[nH]c1CSCCN=C(N)NC#N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 3/20 0.43
▸ HRH3 Q9Y5N1 2/20 0.43
▸ HRH2 P25021 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ SLC22A2 O15244 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ATP4A P20648 1/20 0.42
▸ APEX1 P27695 1/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ ATP4B P51164 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ SLC47A2 Q86VL8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11808533 1.00 HRH4 (0.43) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL11066523 0.86 MEN1 (0.42) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL11075506 0.85 HRH2 (0.47) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL11075504 0.85 HRH2 (0.47) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL10591193 0.85 HRH2 (0.39) HRH4HRH3HRH2MEN1SLC22A2
Cimetidine SCHEMBL11282982 0.85 HRH2 (0.46) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL11006337 0.85 SMN1; SMN2 (0.41) HRH4HRH3HRH2MEN1SLC22A2
Cimetidine SCHEMBL7355211 0.85 HRH2 (0.46) HRH4HRH3HRH2MEN1SLC22A2
Cimetidine SCHEMBL7355215 0.85 HRH2 (0.46) HRH4HRH3HRH2MEN1SLC22A2
SCHEMBL11006612 0.85 SMN1; SMN2 (0.41) HRH4HRH3HRH2MEN1SLC22A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 — — US claimed
US-4973703-A ACTIVATED CARBON IN WATER IN PRESENCE OR ORGANIC ACID MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1990-11-27 — — US disclosed
EP-0317131-A1 Process for purification of N-cyano-N'-methyl-N''-[2-((5-methyl-1H-imidazol-4-yl)methylthio)ethyl]guanidine MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-05-24 — — EP disclosed
US-4293699-A CONTAINING A BENZIMIDAZOLE OR 3-/5,6,7,8-TETRAHYDROIMIDAZO(1,5A)PYRIDINE, ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-10-06 — — US disclosed
US-4287198-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-09-01 — — US disclosed
US-4228291-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-10-14 — — US disclosed
US-4221802-A Pharmacologically active guanidine compounds for inhibiting H-2 histamine receptors SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-09-09 — — US disclosed
US-4154844-A ANTIHISTAMINE, GASTRIC JUICE ANTISECRETORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-15 — — US disclosed
US-4137237-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-01-30 — — US disclosed
US-4104382-A (((THIAZOLYL-, ISOTHIAZOLYL- OR PYRIDYLALKYL)THIO)ALKYL)GUANIDINE SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-01 — — US disclosed
US-4070475-A THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-01-24 — — US disclosed
US-4024271-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-17 — — US disclosed
US-4022797-A PHARMACEUTICALS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-10 — — US disclosed
US-4000302-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-12-28 — — US disclosed
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 — — US disclosed
Send feedback